AGP Executive Report
Last update: 12 hours agoTexas Hemp THC Crackdown: Texas retailers must remove many hemp-derived THC products after the state classifies Delta-8 and other chemically converted THC isomers as Schedule I, while low-dose Delta-9 (≤0.3% by dry weight) can still be sold—prompting lawsuits and store shutdown fears. Federal Policy Timing: U.S. Senate leaders added spending-bill provisions to delay a planned federal ban on most hemp THC products, giving industry more time to push for comprehensive rules. Industry Watch: A biotech “running on empty” report flags cash-runway pressure across smaller life-science firms, underscoring how funding gaps can stall drug development. Medical Cannabis Access: New Hampshire marked 10 years of its medical cannabis program, now serving about 18,000 patients. CBD/Wellness Consumer Angle: A CBD pet-care piece notes some vets use CBD alongside pain meds for arthritis, while anxiety relief for pets appears less consistent. Public Health & Safety: A report on jail mental-health care after a remand prisoner’s death highlights gaps in assessment and support—relevant to broader substance-misuse and health access debates.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
